Yüklüyor......
EZH2 inhibitor GSK343 inhibits sepsis-induced intestinal disorders
Enhancer of zeste homolog 2 (EZH2) is positively associated with poor clinical outcomes in a number of aggressive tumors. Recent studies have demonstrated that inhibition of EZH2 also suppressed the inflammatory response during sepsis. The present study aimed to investigate whether an inhibitor of E...
Kaydedildi:
| Yayımlandı: | Exp Ther Med |
|---|---|
| Asıl Yazarlar: | , , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
D.A. Spandidos
2021
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7967880/ https://ncbi.nlm.nih.gov/pubmed/33747174 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/etm.2021.9854 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|